MULTI-LINK VISION 1007850-18Recalls & reported problems
Abbott Vascular Inc. · MULTI-LINK RX VISION Coronary Stent System 4.00 mm x 18 mm · Class 3 · Implant
All models of MULTI-LINK VISION (19)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08717648050794), received between Nov 8, 2016 and Sep 25, 2020 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Device Dislodged or Dislocated2
- Difficult to Remove1
- Improper or Incorrect Procedure or Method1
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 25, 2020Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A HEAVILY CALCIFIED DE NOVO LESION IN THE MID LEFT ANTERIOR DESCENDING CORONARY ARTERY (MLAD). DURING ADVANCEMENT OF THE RX VISION STENT DELIVERY SYSTEM (SDS), THE STENT DISLODGED PRIOR TO ENTERING THE TUOHY VALVE; HOWEVER, THIS WAS NOT NOTED UNTIL AFTER THE BALLOON WAS INFLATED AT THE LESION. THERE WAS NO REPORTED ADVERSE PATIENT EFFECT OR A CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. ANOTHER RX VISION WAS SUCCESSFULLY IMPLANTED TO COMPLETE THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10589731 ↗MalfunctionNov 8, 2016Difficult to Remove; Improper or Incorrect Procedure or Method; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS A SAPHENOUS VEIN GRAFT TO THE DIAGONAL LEFT ANTERIOR DESCENDING CORONARY ARTERY. AN RX VISION 4 X 18 MM CORONARY STENT SYSTEM WAS PREPPED AND PLACED INSIDE A GRAFT AND WAS POST-DILATED. AFTER INTRAVASCULAR ULTRASOUND, THE STENT COULD NOT BE SEEN. IT WAS DISCOVERED THAT THE STENT HAD COME OFF THE BALLOON AND WAS STUCK BETWEEN THE STYLET AND PROTECTIVE SHEATH COVERING. THIS HAPPENED DURING PREPARATION WITHOUT REALIZING IT HAD COME OFF. IT WAS REPORTED THAT FORCE WAS APPLIED DURING REMOVAL OF THE PROTECTIVE SHEATH. ANOTHER SAME SIZE STENT WAS USED TO TREAT THE VESSEL. THERE WAS NO REPORTED ADVERSE PATIENT EFFECT. THERE WAS NO REPORTED CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6085463 ↗
Other STENT, CORONARY devices
- WALLSTENT® Endoprosthesis H965403130Boston Scientific Corporation · STENT, CORONARY35 reports
- WALLSTENT® Endoprosthesis H965402130Boston Scientific Corporation · STENT, CORONARY23 reports
- Tryton Side Branch Stent T5-2530-191-USTryton Medical, Inc. · Stent, Coronary1 death22 reports
- WALLSTENT® Endoprosthesis H965403330Boston Scientific Corporation · STENT, CORONARY21 reports
- WALLSTENT® Endoprosthesis H965403320Boston Scientific Corporation · STENT, CORONARY10 reports
- WALLSTENT® Endoprosthesis H965403120Boston Scientific Corporation · STENT, CORONARY9 reports
- PALMAZ Balloon Expandable Stent P308Cordis US Corp. · STENT, CORONARY7 reports
- Cobra PzF 170-03-35024Celonova Biosciences, Inc. · Stent, Coronary7 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page